255
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Fluoxetine-induced toxicity results in human placental glutathione S-transferase-π (GST-π) dysfunction

, &
Pages 439-444 | Received 06 Aug 2015, Accepted 10 Jan 2016, Published online: 12 Feb 2016

References

  • Adler V, Yin Z, Fuchs SY, et al. (1999). Regulation of JNK signalling by GSTpi. EMBO J 18:1321–1334.
  • Altshuler LL, Cohen L, Szuba MP, et al. (1996). Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153:592–606.
  • Alwan S, Reefhuis J, Rasmussen SA, et al. (2007). Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684–2692.
  • Aranoff GR, Berstrom RF, Potrattz ST, et al. (1984). Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin Pharmacol Ther 36:138–144.
  • Baranczyk-Kuzma A, Kuzma H, Gutowicz M, et al. (2004). Glutathione S-transferase pi as a target for tricyclic antidepressants in human brain. Acta Biochim Pol 51:207–212.
  • Bebbington PE, Dunn G, Jenkins R, et al. (1998). The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med 28:9–19.
  • Bergstrom RF, Lemberger L, Farid NA, Wolen RL. (1988). Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Phychiatry 153:47–50.
  • Berk M. (2007). Oxidative biology: new intervention opportunities in psychiatry. Acta Neuropsychiatr 19:259–260.
  • Bernardini S, Bernassola F, Cortese C, et al. (2000). Modulation of GST P1-1 activity by polymerization during apoptosis. J Cell Biochem 77:645–653.
  • Bilici M, Efe H, Koroglu MA, et al. (2001). Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51.
  • Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
  • Brunswick DJ, Amsterdam JD, Fawcett J, et al. (2002). Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment. J Affect Disord 68:243–249.
  • Crewe HK, Lennard MS, Tucker GT, et al. (1992). The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol 34:262–265.
  • Dalmizrak O, Kulaksiz-Erkmen G, Ozer N. (2011). The inhibition characteristics of human placental glutathione S-transferase-π by tricyclic antidepressants: amitriptyline and clomipramine. Mol Cell Biochem 355:223–231.
  • Dalmizrak O, Kulaksiz-Erkmen G, Ozer N. (2012). Possible prenatal impact of sertraline on human placental glutathione S-transferase-π. Hum Exp Toxicol 31:457–464.
  • De Kloet ER, Joels M, Holsboer F. (2005). Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463–475.
  • Ewing G, Tatarchuk Y, Appleby D, et al. (2015). Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome. Clin Pharmacokinet 54:359–370.
  • Gram LF. (1994). Drug therapy: fluoxetine. N Eng J Med 17:1354–1361.
  • Habig WH, Jakoby WB. (1981). Assays for differentiation of glutathione S-transferases. Methods Enzymol 77:398–405.
  • Hallberg P, Sjöblom V. (2005). The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 25:59–73.
  • Hayes JD, Flanagan JU, Jowsey IR. (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88.
  • Hendrick V, Stowe ZN, Altshuler LL, et al. (2003). Placental passage of antidepressant medications. Am J Psychiatry 160:993–996.
  • Henry ME, Schmidt ME, Hennen J, et al. (2005). A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 30:1576–1583.
  • Hiemke C, Hartter S. (2000). Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85:11–28.
  • Inkielewicz-Stepniak I. (2011). Impact of fluoxetine on liver damage in rats. Pharmacol Rep 63:441–447.
  • Kallen B, Otterblad Olausson P. (2006). Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21:221–222.
  • Ketterer B. (2001). A bird’s eye view of the glutathione transferase field. Chem Biol Interact 138:27–42.
  • Koenig AM, Thase ME. (2009). First-line pharmacotherapies for depression – what is the best choice? Pol Arch Med Wewn 119:478–486..
  • Mannervik B, Board PG, Hayes JD, et al. (2005). Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 401:1–8.
  • Morrison JL, Riggs KW, Rurak DW. (2005). Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev 17:641–650.
  • Myren M, Mose T, Mathiesen L, Knudsen LE. (2007). The human placenta-An alternative for studying foetal exposure. Toxicol In Vitro 21:1332–1340.
  • Nakhai-Pour HR, Broy P, Berard A. (2010). Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 13:1031–1037.
  • Pato MT, Murphy DL, DeVane CL. (1991). Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 11:224–225.
  • Pedersen LH, Henriksen TB, Vestergaard M, et al. (2009). Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339:6.
  • Pérez V, Puiigdemont D, Gilaberte I, et al. (2001). Augmentation of fluoxetine’s antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. J Clin Psychopharmacol 21:36–45.
  • Ralat LA, Colman RF. (2004). Glutathione S-transferase pi has at least three distinguishable xenobiotic substrate sites close to its glutathione-binding site. J Biol Chem 279:50204–50213.
  • Reis M, Kallen B. (2010). Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 40:1723–1733.
  • Sandson NB, Armstrong SC, Cozza KL. (2005). An overview of psychotropic drug-drug interactions. Psychosomatics 46:464–494.
  • Schildkraut JJ. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522.
  • Segel IH. (1975). Enzyme kinetics. New York: A Wiley-Interscience Publication
  • Shearer WT, Shreiner RL, Marshall RE. (1972). Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr 81:570–572.
  • Strange RC, Spiteri MA, Ramachandran S, Fryer AA. (2001). Glutathione-S-transferase family of enzymes. Mutat Res 482:21–26.
  • Townsend DM, Manevich Y, Hutchens S, et al. (2009). Novel role for glutathione S-transferase π: regulator of protein – glutathionylation following oxidative and nitrosative stres. J Biol Chem 284:436–445.
  • Wong DT, Perry KW, Bymaster FP. (2005). Case history: the discovery of fluoxetine hydrochloride. Nature 4:764–774.
  • Zafir A, Ara A, Banu N. (2009). Invivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 33:220–228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.